Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
54 Thurgauerstrasse, Floor 5, Zürich, ZH, 8050, CH
Otulfi was approved in September 2024 by the FDA for both subcutaneous and intravenous formulations as a biosimilar to Stelara.
SELARSDI injection is approved for the treatment of psoriatic arthritis, plaque psoriasis, Crohn’s disease, ulcerative colitis, pediatric plaque psoriasis and pediatric psoriatic arthritis.
By: Charlie Sternberg
The regulatory approval process is expected to be completed by the fourth quarter of 2025.
AVT05 is Alvotech’s proposed biosimilar to Simponi and Simponi Aria, which are prescribed to treat a variety of inflammatory conditions.
Understand drug patents, FDA exclusivity and the future of intellectual property. See how Humira's exclusivity loss illustrates key pharma industry challenges.
Basilea's antibiotic ZEVTERA approved for three indications, Vanda Pharmaceuticals' Fanapt approved for acute Bipolar I Disorder.
By: Kristin Brooks
Teva is Alvotech’s strategic partner for the exclusive commercialization of SIMLANDI in the United States.
Teva gains exclusive commercialization of two new biosimilar candidates in the U.S. and line extensions of two current biosimilar candidates.
By: Anthony Vecchione
Tanksley succeeds Reem Malki, who is stepping down.
Initial pipeline contains biosimilar candidates addressing multiple therapeutic areas.
By: Contract Pharma
Biosimilar of AbbVie’s Humira to be developed and supplied by Alvotech
By: Tim Wright
Enter into an exclusive partnership for the commercialization of key biosimilars in Canada.
Alvotech Contract Services to make one of Prestige’s biosimilar candidates
Will partner for the commercialization of key biosimilar in select emerging markets
For the exclusive partnership and supply to commercialize Alvotech’s ustekinumab biosimilar (Stelara) in Japan
By: Betsy Louda
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !
